---
title: "Antibiotics and infection"
---

### Infection and Antibiotics

------------------------------------------------------------------------

### Inflammation

#### Acute Inflammation

-   **Increased vascular permeability** leading to the migration of:
    -   **Neutrophils** initially.
    -   **Monocytes** later.
-   **Phagocytosis**: These cells phagocytose foreign material.
-   **Leucocytes**: Minimal in acute infection.

#### Chronic Infection

-   **Causes**:
    -   Resistant organisms exhibiting a low-grade immune reaction.
    -   Persistent non-degradable toxins (e.g., silica).
    -   Immune-mediated reactions.
-   **Predominant cells**:
    -   **Mononuclear cells**:
        -   Macrophages (the main cell).
        -   Lymphocytes.
        -   Plasma cells.
    -   **Fibroblasts**.
    -   **Eosinophils** (in immune reactions).

#### Macrophage Stimulation

-   **Two mechanisms**:
    1.  Secretion of **gamma interferon** by **T cells** (lymphocytes).
    2.  Secretion of **endotoxin** by microbes.

#### Consequences of Chronic Macrophage Activity

-   **Secretion of multiple growth factors and proteases**:
    -   Leads to tissue destruction, neovascularisation, and fibroblast proliferation.
    -   **Stimulation of lymphocytes** further increases gamma interferon production, creating a vicious cycle that stimulates macrophages.

------------------------------------------------------------------------

### Bacteriology

#### Bacterial Characteristics

-   **Prokaryotic**: Bacteria have no nucleus.
-   No mitochondria or lysosomes.
-   They do have a **cell wall**.

#### Gram Staining

-   Based on the ability of bacterial cell walls to retain stains.
    -   **Gram-positive bacteria**: Retain **blue stain** (crystal violet idium).
    -   **Gram-negative bacteria**: Retain **pink stain** (safranin).

#### Bacterial Shapes

-   **Cocci**: Spherical bacteria.
-   **Bacilli**: Rod-shaped bacteria.

------------------------------------------------------------------------

### Bacteriology of Periprosthetic Infections

#### Staphylococcus Species

-   **Staphylococcus Aureus**:
    -   **Coagulase-positive**.
    -   Produces **fibrin** from fibrinogen, promoting clotting and protecting against phagocytosis, making it very virulent.
-   **Staphylococcus Epidermidis**:
    -   **Coagulase-negative**, generally less virulent.
    -   However, in the presence of a **Biofilm**, its virulence increases.

#### Glycocalyx and Biofilm

-   **Glycocalyx**:
    -   A protective layer (protein or polysaccharide) secreted by bacteria.
    -   Provides resistance to phagocytosis and enhances adhesion to foreign materials (e.g., metal implants).
-   **Biofilm**:
    -   A community of bacteria encased in a glycocalyx.
    -   More resistant to phagocytosis and better at adhering to foreign materials.
    -   Biofilm formation takes around **4 weeks**.

------------------------------------------------------------------------

### MRSA (Methicillin Resistant Staphylococcus Aureus)

-   MRSA is a strain of **Staphylococcus Aureus** resistant to **Beta-Lactam antibiotics**, including Methicillin.
-   **Resistance**:
    -   MRSA produces a **penicillin-binding protein** that reduces the action of antibiotics.
    -   MRSA is not necessarily more virulent but much harder to treat due to its resistance.

------------------------------------------------------------------------

### Antibiotics

#### Beta-Lactam Antibiotics

-   **Bactericidal**: Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
-   **Examples**:
    -   **Penicillins**.
    -   **Cephalosporins** (4 generations):
        -   **1st Generation**: Cephazolin.
        -   **2nd Generation**: Cefuroxime.
        -   **3rd Generation**: Ceftriaxone.
        -   **4th Generation**: Cefpirone.

#### Co-Amoxiclav

-   A combination of **penicillin** and a **beta-lactamase inhibitor** (clavulanic acid) that prevents beta-lactamase from deactivating the antibiotic.

#### Aminoglycosides

-   **Bactericidal**: Inhibit protein synthesis by binding to the 30S subunit of ribosomal RNA.
-   **Predominantly** effective against Gram-negative bacteria.
-   **Examples**: Gentamicin, Tobramycin.

#### Macrolides

-   **Inhibit protein synthesis** by binding to the 50S subunit of ribosomal RNA.
-   **Examples**: Erythromycin, Clindamycin.

#### Quinolones

-   **Inhibit DNA gyrase**.
-   **Example**: Ciprofloxacin.

#### Glycopeptides

-   **Inhibit cell wall synthesis**.
-   Provide good coverage for both Gram-positive and Gram-negative bacteria.
-   **Examples**: Teichoplanin, Vancomycin.

#### Rifampicin

-   **Bactericidal**: Inhibits RNA transcription.

#### Tetracyclines

-   **Bacteriostatic**: Inhibit protein synthesis by binding to the 30S subunit of ribosomal RNA.
-   **Examples**: Tetracycline, Doxycycline.

------------------------------------------------------------------------

### Antibiotic Use in Specific Situations

#### Prophylaxis

-   Administered **within 1 hour** of the incision.
-   Limited to **24 hours** to prevent resistance.
-   Typically, **1st generation cephalosporins** (e.g., Cephazolin) are used, particularly when hardware is involved.

#### Open Fractures (BAPRAS Guidelines)

-   **Augmentin 1.2g IV 8-hourly** or **Cefuroxime 1.5mg 8-hourly** until the wound is closed or up to **72 hours max**.
-   If using **Cefuroxime**, add **Gentamicin** during debridement.
-   For penicillin-allergic patients, use **Clindamycin 600mg QDS**.
-   In gross contamination, consider adding **Metronidazole**.

#### Chronic Infection

-   Commonly caused by **Staphylococcus Aureus** or **Staphylococcus Epidermidis** in hardware-related cases.
-   Biofilm and glycocalyx formation require antibiotics with good bone penetration.
-   **Clindamycin** is recommended for osteomyelitis.

------------------------------------------------------------------------

### Antibiotic Resistance

#### Modes of Resistance

1.  **Intrinsic Resistance**:
    -   Due to structural or metabolic properties that make bacterial cell walls resistant.
2.  **Acquired Resistance**:
    -   Occurs when resistant strains develop from previously sensitive populations, mediated by **plasmids** and **transposons**.

------------------------------------------------------------------------

### Typical Bacteria in Specific Situations

| **Condition** | **Organism(s)** |
|-------------------------------|-----------------------------------------|
| Cellulitis | Staphylococcus Aureus |
| Necrotizing Fasciitis | Group A Streptococcus, Polymicrobial |
| Gas Gangrene | Clostridia |
| Marine Infections | Mycobacterium Marinum, Vibro Vulnificus |
| Rose Thorn Inoculation | Sporothrix Schenckii |
| Human Bite | Eikenella Corrodens, Staphylococcus Aureus |
| Cat Bite | Pasteurella Multocida, Staphylococcus Aureus |
| Dog Bite | Pasteurella Multocida, Strep Viridans, Staphylococcus Aureus |
| Pig Bite | Polymicrobial |
| Periprosthetic Infection | Staphylococcus Aureus, Coagulase-negative Staphylococcus (Epidermidis) |
| Open Fracture | Staphylococcus, Streptococcus, Anaerobic bacteria |
| Shoe Puncture | Pseudomonas |
| Meat Handling | Brucella |
| Sickle Cell | Salmonella |
| IV Drug Abuse | Pseudomonas |
| Fungal Nail Bed | Trichophyton Rubrum |

------------------------------------------------------------------------

### Bacterial Classification by Gram Stain and Shape

| **Gram-Positive**     | **Gram-Negative**               |
|-----------------------|---------------------------------|
| **Cocci**             | **Cocci**                       |
| Staphylococcus Aureus | Neisseria                       |
| Enterococcus          |                                 |
| Streptococcus         |                                 |
| **Bacilli**           | **Bacilli**                     |
| Clostridia            | Pseudomonas                     |
| Actinomyces           | E. Coli, Salmonella, Klebsiella |
|                       | Eikenella                       |
